Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Prevention of respiratory infections with alpha- and gamma-herpesviruses in weanling foals by using a modified live intra-nasal equine influenza vaccine.
Abstract: This study aimed to determine if the administration of a modified live equine influenza virus vaccine (FluAvert) to foals would positively impact their health and reduce colonization of their upper airways with equine herpesviruses (EHV) during the weaning period. A single dose of FluAvert was given to 20 healthy foals 7 days prior to being weaned; 20 healthy foals served as unvaccinated controls. Nasal secretions and blood were collected before vaccination, the day of weaning, and weekly thereafter for 3 weeks. Nasal secretions were tested by quantitative polymerase chain reaction (qPCR) for EHV-1, -2, -4 and -5. Whole blood was analyzed for a complete blood cell count and fibrinogen concentration. Physical assessments were made daily. The use of FluAvert was associated with a better clinical outcome. However, the equine influenza virus (EIV) vaccine did not influence selected hematological parameters and kinetics of herpesviruses. The clinical benefit observed in vaccinates may explain the perception that the EIV vaccine induces cross-protection against respiratory agents. La présente étude visait à déterminer si l’administration d’un vaccin vivant modifié du virus de l’influenza (FluAvert) à des poulains affecterait positivement leur santé et réduirait la colonisation de leurs voies respiratoires supérieures par les herpesvirus équins (EHV) durant la période de sevrage. Une dose unique de FluAvert fut administrée à 20 poulains en santé 7 jours avant le sevrage; 20 poulains en santé ont servi de témoins non-vaccinés. Des sécrétions nasales et du sang furent prélevés avant la vaccination, le jour du sevrage, et de manière hebdomadaire pour les trois semaines suivantes. Les sécrétions nasales furent testées par réaction d’amplification en chaîne par la polymérase quantitative (qPCR) pour EHV-1, -2, -4 et -5. Le sang entier fut analysé pour un dénombrement complet des cellules sanguines et la concentration de fibrinogène. Des examens physiques étaient réalisés quotidiennement. L’utilisation de FluAvert fut associée avec une meilleure issue clinique. Toutefois, le vaccin contre le virus de l’influenza équin (EIV) n’influença pas des paramètres hématologiques sélectionnés et la cinétique des herpesvirus. Les bienfaits cliniques observés chez les chevaux vaccinés pourraient expliquer la perception que le vaccin EIV induit une protection croisée contre des agents infectieux respiratoires.(Traduit par D Serge Messier).
Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.
Publication Date: 2020-05-02 PubMed ID: 32355351PubMed Central: PMC7155874 The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The researchers investigated whether administering a modified live equine influenza virus vaccine (FluAvert) to foals can positively impact their health and reduce colonization of their upper respiratory tracks by equine herpesviruses during their weaning period. While there was a notable clinical benefit seen in vaccinated foals, the vaccine’s impact on selected hematological aspects and kinetics of herpesviruses was not profound.
Methodology
In this study:
- The researchers administered a single dose of FluAvert (a live equine influenza virus vaccine), to 20 healthy foals seven days prior to them being weaned.
- Another 20 healthy foals served as unvaccinated control subjects.
- Both nasal secretions and blood were collected and analyzed from subjects at different stages: before vaccination, on the day of weaning, and weekly for three weeks after.
- Nasal secretions were tested for Equine Herpesviruses EHV-1, EHV-2, EHV-4, and EHV-5 using quantitative polymerase chain reaction (qPCR).
- Comprehensive blood cell count and fibrinogen concentration assessments were done using whole blood samples.
- The researchers also made daily physical assessments.
Findings
After analysis:
- The use of FluAvert was associated with a better clinical outcome in the foals. There was a positive health impact in the vaccinated subjects compared to the control group.
- Interestingly, the equine influenza virus (EIV) vaccine seemed to have no influence on selected hematological parameters and the kinetics of herpesviruses respective to infection progression and recovery.
- Given the observed clinical benefits in vaccinated foals, researchers suggest that the use of the EIV vaccine could give the impression of inducing a cross-protection against other respiratory infectious agents, despite the lack of precise hematological evidence.
The research is important in the management of respiratory health in weanling foals, especially by providing insights on the potential benefits of using FluAvert. However, the influence of EIV vaccine on selected hematological parameters and herpesvirus kinetics require further research to understand the full scope of the vaccine’s impact.
Cite This Article
APA
Salco R, Bowers J, Hernandez V, Barnum S, Pusterla N.
(2020).
Prevention of respiratory infections with alpha- and gamma-herpesviruses in weanling foals by using a modified live intra-nasal equine influenza vaccine.
Can Vet J, 61(5), 517-520.
Publication
Researcher Affiliations
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, One Shields Avenue, Davis, California, USA (Pusterla, Barnum); Harris Farms Horse Division, 27366 West Oakland Avenue, Coalinga, California, USA (Salco, Bowers, Hernandez).
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, One Shields Avenue, Davis, California, USA (Pusterla, Barnum); Harris Farms Horse Division, 27366 West Oakland Avenue, Coalinga, California, USA (Salco, Bowers, Hernandez).
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, One Shields Avenue, Davis, California, USA (Pusterla, Barnum); Harris Farms Horse Division, 27366 West Oakland Avenue, Coalinga, California, USA (Salco, Bowers, Hernandez).
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, One Shields Avenue, Davis, California, USA (Pusterla, Barnum); Harris Farms Horse Division, 27366 West Oakland Avenue, Coalinga, California, USA (Salco, Bowers, Hernandez).
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, One Shields Avenue, Davis, California, USA (Pusterla, Barnum); Harris Farms Horse Division, 27366 West Oakland Avenue, Coalinga, California, USA (Salco, Bowers, Hernandez).
MeSH Terms
- Animals
- Antibodies, Viral
- Herpesviridae Infections / prevention & control
- Herpesviridae Infections / veterinary
- Herpesvirus 1, Equid / immunology
- Horse Diseases / prevention & control
- Horses
- Influenza Vaccines
- Respiratory Tract Infections / prevention & control
- Respiratory Tract Infections / veterinary
References
This article includes 14 references
- Cullinane A, Weld J, Osborne M, Nelly M, Mcbride C, Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.. Vet J 2001 Mar;161(2):174-85.
- Pecoraro HL, Koch D, Bentsen L, Soboll-Hussey G, Landolt GA. Comparison of innate immune responses in equine respiratory epithelial cells to modified-live equine influenza virus vaccine and related wild-type influenza virus. Proceedings of the 32nd Annual Veterinary Medical Forum of the American College of Veterinary Internal Medicine Nashville, Tennessee. June 4 to June 7, 2014.
- Pusterla N, Mapes S, Wademan C, White A, Hodzic E. Investigation of the role of lesser characterised respiratory viruses associated with upper respiratory tract infections in horses.. Vet Rec 2013 Mar 23;172(12):315.
- Mapes S, Leutenegger CM, Pusterla N. Nucleic acid extraction methods for detection of EHV-1 from blood and nasopharyngeal secretions.. Vet Rec 2008 Jun 28;162(26):857-9.
- Bell SA, Balasuriya UB, Gardner IA, Barry PA, Wilson WD, Ferraro GL, MacLachlan NJ. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.. Vet Microbiol 2006 Sep 10;116(4):249-57.
- Back H, Ullman K, Treiberg Berndtsson L, Riihimäki M, Penell J, Ståhl K, Valarcher JF, Pringle J. Viral load of equine herpesviruses 2 and 5 in nasal swabs of actively racing Standardbred trotters: Temporal relationship of shedding to clinical findings and poor performance.. Vet Microbiol 2015 Sep 30;179(3-4):142-8.
- El-Hage CM, Mekuria ZM, Hartley CA, Gilkerson JR. Survey of equine herpesviruses-1, -2, -4 and -5 in 407 horses with and without respiratory disease. I Equine Vet Sci 2016;39:68–69.
- Negussie H, Gizaw D, Tesfaw L, Li Y, Oguma K, Sentsui H, Tessema TS, Nauwynck HJ. Detection of Equine Herpesvirus (EHV) -1, -2, -4 and -5 in Ethiopian Equids with and without Respiratory Problems and Genetic Characterization of EHV-2 and EHV-5 Strains.. Transbound Emerg Dis 2017 Dec;64(6):1970-1978.
- Smith FL, Watson JL, Spier SJ, Kilcoyne I, Mapes S, Sonder C, Pusterla N. Frequency of shedding of respiratory pathogens in horses recently imported to the United States.. J Vet Intern Med 2018 Jul;32(4):1436-1441.
- Pusterla N, Kass PH, Mapes S, Johnson C, Barnett DC, Vaala W, Gutierrez C, McDaniel R, Whitehead B, Manning J. Surveillance programme for important equine infectious respiratory pathogens in the USA.. Vet Rec 2011 Jul 2;169(1):12.
- Pusterla N, Bain F, James K, Mapes S, Kenelty K, Barnett DC, Gaughan E, Craig B, Chappell DE, Vaala W. Frequency of molecular detection of equine herpesvirus-4 in nasal secretions of 3028 horses with upper airway infection.. Vet Rec 2017 Jun 17;180(24):593.
- Pusterla N, Leutenegger CM, Wilson WD, Watson JL, Ferraro GL, Madigan JE. Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time TaqMan PCR.. J Vet Diagn Invest 2005 Nov;17(6):578-81.
- Bradley A, Kinyon J, Frana T, Bolte D, Hyatt DR, Lappin MR. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.. J Vet Intern Med 2012 Sep-Oct;26(5):1121-5.
- Li R, Lim A, Phoon MC, Narasaraju T, Ng JK, Poh WP, Sim MK, Chow VT, Locht C, Alonso S. Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm.. J Virol 2010 Jul;84(14):7105-13.
Citations
This article has been cited 1 times.- Zarski LM, Vaala WE, Barnett DC, Bain FT, Soboll Hussey G. A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1. Front Vet Sci 2021;8:674850.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
